NXP Semiconductors N.V. Common Stock vs Tilray Brands Inc — how do they compare? NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B), while Tilray Brands Inc trades at $3.54 (market cap $530.54M). The key difference: NXP Semiconductors N.V. Common Stock is far larger — about 109.8× Tilray Brands Inc's market cap, and NXP Semiconductors N.V. Common Stock pays a 1.76% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold NXP Semiconductors N.V. Common Stock for 0 Days and Tilray Brands Inc for 31 Days on average.
| NXPI | TLRY | |
|---|---|---|
Market Cap | $58.27B | $530.54M |
Volume | 3,950,702 | 9,099,075 |
Sector | Technology | Health |
52-Week High | $332.67 | $21.00 |
52-Week Low | $184.19 | $3.57 |
Typical Hold Time | 0 Days | 31 Days |
Enterprise Value | $66.38B | $684.46M |
Dividend Yield | 1.76% | — |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Tilray Brands (TLRY) trades at $3.59, down 3.36% on the day and near 52-week lows, with bearish technical indicators dominating. The company reported $821 million in revenue for 2025 but posted a massive $2.19 billion net loss due to impairment charges. Recent earnings have consistently missed expectations, though analyst consensus remains cautiously optimistic with a $65.01 price target. The stock faces significant headwinds from ongoing profitability challenges and cannabis industry volatility.
TLRY presents a high-risk opportunity with potential upside if management can achieve profitability and capitalize on cannabis reform catalysts. However, persistent losses, negative cash flow, and competitive pressures create substantial downside risk. Investors should weigh the speculative nature against potential regulatory catalysts in the coming months.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.
Read more on NXPI →Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.
Read more on TLRY →